25-Sep-2025
Designed protein switches may lead to safer, smarter medicines
University of Washington School of Medicine/UW MedicinePeer-Reviewed Publication
A new molecular switch, created through protein design, may be a potential way to control when drugs are active or inactive in the body. Researchers hope this approach is a starting point for further developments to reduce side effects from cancer drugs or antibody therapies. This type of designed molecular switch has already been shown to increase the speed of a COVID test. The scientists have also created a switchable version of interleukin-2 in a effort to manage the side effects of this potentially powerful cancer drug.
- Journal
- Nature
- Funder
- Audacious Project, Bill and Melinda Gates Foundation, Howard Hughes Medical Institute, Nordstrom Barrier Institute for Protein Design Directors Fund, Microsoft, NIH/National Institutes of Health, NIH/National Cancer Institute, U.S. National Science Foundation, Deutsche Forschungsgemeinschaft, U.S. Department of Energy, CRI Irvington Postdoctoral Fellowship